Picture of Peptron logo

087010 Peptron Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual income statement for Peptron, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3,1216,6255,8143,3423,152
Cost of Revenue
Gross Profit1,1364,5433,3201,1411,107
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses20,90022,29921,06019,23319,689
Operating Profit-17,779-15,674-15,246-15,891-16,537
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-18,335-15,284-15,067-15,941-21,619
Provision for Income Taxes
Net Income After Taxes-18,382-15,042-15,063-15,922-22,034
Net Income Before Extraordinary Items
Net Income-18,382-15,042-15,063-15,922-22,034
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-18,382-15,042-15,063-15,922-22,034
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1,152-706-702-750-962
Dividends per Share